Results 121 to 130 of about 16,252 (181)
The untransfusable patient. [PDF]
Webert KE, Zeller MP.
europepmc +1 more source
Identification of Candidate Blood Biomarkers of Recombinant Human Erythropoietin Administration Using Targeted Polar Metabolomics by HILIC-MS/MS. [PDF]
Salamin O +5 more
europepmc +1 more source
Personalized Therapeutic Advances in Erythropoietin Signaling: From Anemia Management to Extensive Clinical Applications. [PDF]
Creangă EC +4 more
europepmc +1 more source
CERA Detection and Stability in Blood Versus Urine. [PDF]
Salamin O +4 more
europepmc +1 more source
[Recombinant human erythropoietin].
openaire +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Recombinant Human Erythropoietin
DICP, 1989Erythropoietin is produced mainly by the kidneys and stimulates erythropoiesis in the bone marrow. Chronic renal failure is characterized by anemia, which is principally caused by erythropoietin deficiency. Recombinant human erythropoietin (r-hEPO) corrects the anemia of chronic renal disease and improves patient well-being, exercise tolerance, and ...
M H, Schwenk, C E, Halstenson
+7 more sources
Annual Review of Medicine, 1993
Erythropoietin is the only hematopoietic growth factor that behaves like a hormone. Produced in the kidneys and the liver, erythropoietin interacts with erythroid progenitor cells in the bone marrow to promote their proliferation and maintain their viability. Erythropoietin production is regulated at the level of its gene by tissue oxygenation; hypoxia
A, Besarab, A J, Erslev
openaire +4 more sources
Erythropoietin is the only hematopoietic growth factor that behaves like a hormone. Produced in the kidneys and the liver, erythropoietin interacts with erythroid progenitor cells in the bone marrow to promote their proliferation and maintain their viability. Erythropoietin production is regulated at the level of its gene by tissue oxygenation; hypoxia
A, Besarab, A J, Erslev
openaire +4 more sources
Testing for recombinant erythropoietin
American Journal of Hematology, 2007AbstractErythropoietin (Epo) is a glycoprotein hormone that promotes the production of red blood cells. Recombinant human Epo (rhEpo) is illicitly used to improve performance in endurance sports. Doping in sports is discouraged by the screening of athletes for rhEpo.
Joris R, Delanghe +2 more
openaire +2 more sources
Recombinant erythropoietin in urine
Scandinavian Journal of Medicine & Science in Sports, 2000An artificial hormone taken to boost athletic performance can now be detected. Erythropoietin is a hormone that stimulates the production of new red blood cells (erythropoiesis). Although athletes use recombinant human erythropoietin illicitly to boost the delivery of oxygen to the tissues and enhance their performance in endurance sports, this ...
F, Lasne, J, de Ceaurriz
openaire +2 more sources
Recombinant erythropoietin overdose
The American Journal of Emergency Medicine, 1993Deliberate self-administration of recombinant human erythropoietin (rHuEpo) in a patient without anemia has never been documented. The case of a 62-year-old man who worked in an allied health care field and surreptitiously injected the drug, causing his hematocrit to increase to a dangerously high level is presented.
K R, Brown, W, Carter, G E, Lombardi
openaire +2 more sources

